Association of Diabetes Care & Education Specialists

Home Page
Your Personalized Guide
to AADE Resources
My Profile
My Memberships
My Purchases
My Open Invoices
Join Online
Online Store
Make a Donation
Access My Learning
Access AADE7 System
Find a Diabetes Educator
Find an Accredited DSME Program
Apply For/Manage My DEAP Application

Event Profile

New Treatment Option for Painful Diabetic Neuropathy, HFX for PDN

September 22, 2021

Location: Online


Event Date: Wednesday, September 22, 2021
Event Time: 1:00 - 2:00 pm EDT

Please Note: All times are Eastern. Our webinars begin at 1:00 pm Eastern / 12:00 pm Central / 11:00 am Mountain / 10:00 am Pacific.


Treatment options for Painful Diabetic Neuropathy have been limited in efficacy and adherence. In July, the FDA approved the only spinal cord stimulation (SCS) therapy with a specific indication for painful diabetic neuropathy (PDN). The HFX Solution, which uses 10 kHz Therapy, has been shown to provide an average 76% pain relief in the treatment of diabetic neuropathy. During this webinar we will:

  • Review the outcomes of the SENZA PDN RCT that compared optimized conventional medical management (CMM) for PDN to 10 kHz Therapy.
  • Show how the HFX Solution can provide significant and long-lasting pain relief, as well as improved neurologic response and quality of life.
  • Help identify appropriate PDN candidates in your practice and find out how to access this breakthrough treatment option for their pain.
Join us to learn how the HFX Solution could help your patients with diabetes.

This webinar is sponsored by Nevro Corp.



  • Review conventional treatment options for diabetic neuropathy
  • Learn how HFX 10 kHz spinal cord stimulation works and review RCT outcomes
  • Learn how to identify treatment candidates and what to expect from the HFX trialing procedure


1. Overview of Conventional Medical Management (CMM) / Historic treatment options
   - ADA first line treatment: Pregabalin, Duloxetine, Gabapentin
   - Common side effects: memory loss, dizziness, exhaustion, weight gain, nightmares

2. Introduction to the HFX Solution as a new nonpharmacologic PDN treatment
   - The first and only spinal cord stimulation (SCS) therapy approved by the FDA to treat Painful Diabetic Neuropathy (PDN)
   - Established therapy/treatment with 70,000+ patients
   - Minimally invasive procedure

3. SENZA PDN RCT outcomes*
   - 85% experienced 50% or greater pain relief
   - 76% average pain relief
   - Improvement in sleep
   - 62% improved neurological response

4. Patients who can benefit from the HFX Solution
   - HbA1C ≤10%
   - Tried and failed 2+ CMM medications
   - Lower limb pain intensity of 5cm or more on 10-cm visual analogue scale (VAS)
   - Deemed to be medically suitable for the procedure

5. Patient Testimonials / Experiences

*Petersen, E, et. al. Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy A Randomized Clinical Trial. JAMA Neurology, April 2021.

Intended Audience

This activity is designed for diabetes care and education specialists, including nurses, dietitians, pharmacists, nurse practitioners, clinical nurse specialists, PAs, physicians, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.


This webinar is FREE for ADCES members and non-members.

David G. Armstrong, MD, DPM, PHD
Professor of Surgery, Keck School of Medicine of University of Southern California (USC)
Director, Southwester Academic Lim Salvage Alliance (SALSA)

Dr. Armstrong is Professor of Surgery with Tenure at the University of Southern California. Dr. Armstrong holds a Master of Science in Tissue Repair and Wound Healing from the University of Wales College of Medicine and a PhD from the University of Manchester College of Medicine, where he was appointed Visiting Professor of Medicine. He is founder and co-Director of the Southwestern Academic Limb Salvage Alliance (SALSA).

Dr. Armstrong has produced more than 575 peer-reviewed research papers in dozens of scholarly medical journals as well as over 100 books or book chapters. He is founding co- Editor of the American Diabetes Association’s (ADA) Clinical Care of the Diabetic Foot, now entering its fourth edition.

Dr. Armstrong is Director of USC’s National Science Foundation (NSF) funded Center to Stream Healthcare in Place (C2SHiP) which places him at the nexus of the merger of consumer electronics, wearables and medical devices in an effort to maximize hospital-free and activity-rich days.

Dr. Armstrong was selected as one of the first six International Wound Care Ambassadors and is the recipient of numerous awards and degrees by universities and international medical organizations including the inaugural Georgetown Distinguished Award for Diabetic Limb Salvage. In 2008, he was the 25th and youngest-ever member elected into the Podiatric Medicine Hall of Fame. He was the first surgeon to be appointed University Distinguished Outreach Professor at the University of Arizona. He was the first podiatric surgeon to become a member of the Society of Vascular Surgery and the first US podiatric surgeon named fellow of the Royal College of Surgeons, Glasgow. He is the 2010 and youngest ever recipient of the ADA’s Roger Pecoraro Award, the highest award given in the field.

Dr. Armstrong is past Chair of Scientific Sessions for the ADA’s Foot Care Council, and a past member of the National Board of Directors of the American Diabetes Association. He sits on the Infectious Disease Society of America’s (IDSA) Diabetic Foot Infection Advisory Committee and is the US appointed delegate to the International Working Group on the Diabetic Foot (IWGDF). Dr. Armstrong is the founder and co-chair of the International Diabetic Foot Conference (DF-Con), the largest annual international symposium on the diabetic foot in the world. He is also the Founding President of the American Limb Preservation Society (ALPS), a medical and surgical society dedicated to building interdisciplinary teams to eliminate preventable amputation in the USA and worldwide.

Teresa L. Pearson, MS, CNS, Exec MBA, CDCES, FADCES
President, Innovative Healthcare Designs, LLC
2019 Recipient ADCES Distinguished Service Award
Executive Editor of ADCES In Practice

Ms. Pearson received a Bachelor of Science degree from Winona State College-School of Nursing in Winona, Minnesota. Subsequently she obtained a Master of Science degree from the University of Minnesota-School of Nursing in Minneapolis, and a Mini-MBA in Health Care Administration from the University of St. Thomas, also in Minneapolis. In addition, she is a Certified Diabetes Care and Education Specialist, and a Certified Trainer in Choices and Changes from the Bayer Institute.

Author or coauthor of 40 journal and newsletter articles, book chapters, and audio and video programs, Ms. Pearson has written about quality improvement intervention in diabetes care, primary care and diabetes self-management, and identifying individuals at risk for developing type 2 diabetes. She is is Executive Editor of ADCES In Practice.

Ms. Pearson is a member of the Association of Diabetes Care & Education Specialists, having served as a past First Vice President. Additionally, Ms. Pearson has served the Association of Diabetes Care & Education Specialists, Professional Section; the European Association for the Study of Diabetes; and the Minneapolis-St. Paul Diabetes Educators. She received the Lifetime Achievement Award from the Minnesota Department of Health and Distinguished Service Award from the Association of Diabetes Care & Education Specialists.


Test Your Computer

To ensure that your participation is successful, please test your system as soon as possible so if you do have technical challenges, you will have time to get them sorted out. Click here to test your computer.

System Requirements

While you can participate with a 56K dialup internet connection, it is recommended that you have a high-speed broadband (or better) internet connection. Please be sure you close as many open programs on your system as possible. Click here for operating system requirements.

Share with friends: